Top 50 Life Science Angel Investors in Europe in October 2023
Top 50 Life Science Angel Investors in Europe in October 2023
| Investor | Life Science Europe investments |
|---|---|
| Jonathan Milner | 7 |
| Nadav Rosenberg | 4 |
| Stefano Bernardi | 3 |
| Ed Parkinson | 2 |
| Holger Hübner | 2 |
| Nico Wittenborn | 2 |
| Darrin Disley | 2 |
| Nicholas Edwards | 2 |
| David Helgason | 2 |
| Jan Hruska | 2 |
| Sauli Törmälä | 2 |
| Luc Vauterin | 2 |
| Leena Niemistö | 2 |
| Mike Novogratz | 2 |
| Carsten Maschmeyer | 2 |
| Thor Bjorgolfsson | 2 |
| Jude Gomila | 2 |
| Mark Evans | 2 |
| Pierre Drion | 2 |
| Annie Vereecken | 2 |
| Ian Hogarth | 2 |
| Andrew Keys | 2 |
| Fidji Simo | 1 |
| Jon Oringer | 1 |
| Inaki Berenguer | 1 |
| Michelle Tempest | 1 |
| Sami Mikati | 1 |
| Mariliis Holm | 1 |
| Arturo Elizondo | 1 |
| Bertrand Jacquelot | 1 |
| David Brandes | 1 |
| Milad Alucozai | 1 |
| David Lucas | 1 |
| Arnaldo Marziali | 1 |
| Laura Iris Ferro | 1 |
| Sophia Bendz | 1 |
| Sharaf Yamani | 1 |
| Josefin Landgård | 1 |
| Ritu Bansal-Mutalik | 1 |
| Barbara Korte-Sturm | 1 |
| Ryan Bethencourt | 1 |
| Balaji Srinivasan | 1 |
| Arman Anatürk | 1 |
| Fiona Pathiraja | 1 |
| Chris Leiter | 1 |
| Jon Oringer | 1 |
| Kristian Ranta | 1 |
| Sebastian Lombardo | 1 |
| Simon Galbraith | 1 |
| John Anthony Knight | 1 |
Get 300+ niche investors in 2 minutes.
Find who invests in your industry, stage, and region in our 200k+ database with AI-powered matching.
Find investors — It's Free!Trusted by 21,000+ founders from:
Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.
Show more...Investment focus
- Biotechnology, Health Care, Medical
- Seed, Series A, Series B
- United Kingdom, United States, Canada
Portfolio highlights
- Mogrify — Mogrify is pioneering a new class of in vivo reprogramming therapy and transforming the development of ex vivo cell therapy.
- PharmEnable — Designing the next generation of small molecule drugs. Replicating the specificity of biologics in the scalable form of a small molecule.
- Pencil Biosciences — Next Generation Genome Editing Tool
Nadav leads Taboola’s expansion and operations in Europe and Australia.Prior to joining Taboola, Nadav was a member of the founding team of Groupon UK & IR, taking part in building and managing Groupon’s business in the UK.Before joining Groupon, Nadav worked as a strategy consultant with McKinsey & Company in London.Nadav isbased in London and holds an MBA from INSEAD, France.
Show more...Investment focus
- Biotechnology, Artificial Intelligence, Pharmaceutical
- Seed, Pre-Seed, Series A
- United Kingdom, Israel, Singapore
Portfolio highlights
- thymia — Making mental health as objectively measurable as physical health.
- Exogene — Exogene is a biotechnology company accelerating the discovery of T-cell-receptor(TCR)-based cancer immunotherapies for solid tumours by combining deep learning and high-throughput TCR-antigen screening. Exogene is building a computational platform to quickly and inexpensively identify new tumour targets shared across cancer patients, as well assafe and effective TCRs against these tumour targets for therapeutic application. Their mission is to develop better TCR-based immunotherapies, faster and at a fraction of the cost.
- Loops — Loops is a no-code analytics platform that provides product and data teams with growth opportunities hidden in their data.
Stefano Bernardi is the Investment Director, Climate at Fondazione ENEA Tech.
Show more...Investment focus
- Software, Biotechnology, Cryptocurrency
- Seed, Pre-Seed, Funding Round
- Italy, France, Norway
Portfolio highlights
- Freatic — We bridge the gap between individuals with untapped knowledge and actors who can take advantage of these opportunities.
- Eden Bio — Eden Bio is a biotech using machine learning to guide the genetic engineering of microorganism strain optimisation, improving protein yield.
- CaSRevolution — A novel disease-modifying approach against neurodegeneration
Ed Parkinson
Show more...Investment focus
- Software, Health Care, Life Science
- Seed
- United Kingdom
Portfolio highlights
- Antiverse — Designing biologics for 100 challenging targets
Holger Hübner
Show more...Investment focus
- B2B, SaaS, Audio
- Seed, Pre-Seed
- Germany
Portfolio highlights
- musicube — Good music deserves to be found. That is why musicube develops revolutionary music search technology. Music streaming services and other companies can forward any user request to musicube and get back high quality data in real time (e.g. to return playlists etc.).
- RetroBrain R&D GmbH — Memore gamifies proven dementia therapies into a gesture controlled medical video game. It incorporates and gamifies proven therapies, delaying the effects of dementia and mild cognitive impairment, enabling elderly people without prior gaming experience to utilize the gaming suite easily.Memore works both therapeutically and preventatively withnursing rehabilitation. It was founded in 2014 and is based in Hamburg, Germany.
- HorseAnalytics — HorseAnalytics empowers horse enthusiasts to monitor and improve health and training of horses by applying reliable technologies from health and sports supervision and combining constant and real-time scientific analytics.
Nico Wittenborn is an Investor at Adjacent.
Show more...Investment focus
- Wellness, Software, Health Care
- Seed, Series A, Series B
- United States, Germany, Belgium
Portfolio highlights
- Captions — Say hello to Captions, the only camera and editing app that automatically transcribes, captions and clips your talking videos for you.
- Backbone — Backbone is a mobile gaming controller with intuitive controls, clickable thumbsticks & zero latency that works with cloud and remote gaming.
- Momentum — Momentum builds fundraising software and expert guidance for nonprofits
Darrin Disley is the CEO, Director & Investor at Mogrify. He attended University of Cambridge.
Show more...Investment focus
- Biotechnology, Health Care, Big Data
- Seed, Series A, Funding Round
- United Kingdom
Portfolio highlights
- bit.bio — Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell. Their mission is coding cells for health. To do so, we apply the principles of computation to biology. Bit.bio's current focus is to develop a scalable technology platform capable of producing consistent batches of every human cell. Thishas the potential to unlock a new generation of medicine: it will enable research and drug discovery to move on from inappropriate models and work with the cells that actually are affected by the human disease. A scalable platform of consistent cells will also be the basis for a new generation of cell and tissue therapies. To achieve our goals, we have assembled a team of pioneers in stem cells, cellular reprogramming, mathematical modeling, and cell therapy. Collaboration is at the heart of bit.bio. We are empirical, highly ambitious, and driven by a common purpose.
- Mogrify — Mogrify is pioneering a new class of in vivo reprogramming therapy and transforming the development of ex vivo cell therapy.
- Desktop Genetics — Desktop Genetics is an international biotechnology company established in 2012 to help researchers discover and treat the root genetic causes of human disease. Today, Desktop Genetics is a recognised leader in genome editing technology, staffed by dedicated team of genome editing experts, bioinformaticians and data scientists, driven by thereal-world impact of CRISPR technology.They have invested four years developing their core technology, DESKGEN AI, trained on the largest database of genome editing data in the world. DESKGEN AI powers their flagship DESKGEN CRISPR Library product range, which enables the work of their pharma, biotech and academic customers working in drug discovery and functional genomics. Desktop Genetics' tools and technologies are used by over 1800 organisations all over the world, and their projects contribute directly to several key partnerships to bring CRISPR into the clinic. The company has received awards from Fast Company, Kairos 50 and SxSW Interactive.
Nick serves as the Chairman of Prescient’s Board of Directors. He holds a degree in physiological sciences from The Queen’s College, University of Oxford, and completed his training in clinical medicine (BM, BCh) at Green College (now Green Templeton College), University of Oxford. Nick practiced in the areas of cardiology and general surgerybefore joining Andersen Consulting (now known as Accenture), eventually becoming the global leader of Accenture’s pharmaceutical R&D business during his 18-year tenure. In 2005, he founded Kinapse to provide consulting and outsourcing services to the pharmaceutical industry. Nick served as Kinapse’s Chairman until the company was sold to HgCapital in early 2016.
Show more...Investment focus
- Medical, Health Care, Life Science
- Seed, Funding Round
- United Kingdom
Portfolio highlights
- Oxford Medical Products — Oxford Medical Products is a UK-based biotechnology start-up revolutionising the weight-loss treatment space with its hydrogel-based technology.
David is a technologist, the founder of Unity Technologies, non-exec director to others, and a restless entrepreneur with a passion for creating feedback loops between innovation and teams and products, applying new and old business models to changing industries, and pushing people to do the very best they can do.David's background is inprogramming, an assortment of university dabbling, creating companies, and helping entrepreneurs. He served as CEO of Unity Technologies since co-founding it in 2003 and until October 2014, with an unflinching vision to democratize game development, and to develop technology and business models for the next phase of the games industry. David Helgason attended the University of Copenhagen.
Show more...Investment focus
- Software, Gaming, Information Technology
- Seed, Pre-Seed, Funding Round
- United States, Denmark, Finland
Portfolio highlights
- Isometric — Isometric is a carbon removal registry and science platform
- TreesPlease Games — TreesPlease Games develops various computer and online games. The company is headquartered in London.
- Scriptic — Scriptic, interactive story games on mobile.
Jan Hruska
Show more...Investment focus
- Medical, Health Care, Life Science
- Seed, Funding Round
- United Kingdom
Portfolio highlights
- Oxford Medical Products — Oxford Medical Products is a UK-based biotechnology start-up revolutionising the weight-loss treatment space with its hydrogel-based technology.
Sauli Törmälä is the Board Member, CFO at Promilless Oy. He attended University of Oulu.
Show more...Investment focus
- Life Science, Biotechnology
- Seed
- Finland
Portfolio highlights
- Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
Luc Vauterin - Board Member @ ONTOFORCE
Show more...Investment focus
- Life Science, Data Integration, Data Visualization
- Seed, Series A
- Belgium
Portfolio highlights
- ONTOFORCE — ONTOFORCE creates and implements pioneering semantic search technology for information management. Our user-friendly data search platform DISQOVER builds uniquely intelligent links between heterogeneous data sources, allowing everybody to become a data scientist.
Leena Niemistö
Show more...Investment focus
- Health Care, Software, E-Commerce
- Seed, Funding Round, Pre-Seed
- Finland, United States
Portfolio highlights
- #Rens — RENS Original is the World's First Sneaker made from recycled coffee and plastic. We know you've been drinking it, now it is time to wear it.
- Vapaus — A circular economy startup Vapaus provides sustainable mobility solutions – Employee benefit bicycles and shared electric vehicles as a ready-to-use serviceWith its services, Vapaus supports customers’ to create and strengthen a better experience of the work community, to save on the costs of commuting and business travels, and to move towardssmarter and more environmentally friendly modes of transport, both at work and in employees’ leisure time.Every kilometer traveled by the Vapaus mobility solution removes carbon dioxide from the air, helping not only the environment but also customers on their way to carbon neutrality. The mission of Vapaus is to be a global leader when it comes to sustainable Corporate Mobility.
- Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
Michael E. Novogratz is the CEO of Galaxy Investment Partners. He was formerly a principal and a member of the board of directors of Fortress Investment Group LLC and Chief Investment Officer of the Fortress Macro Fund. Mr. Novogratz joined Fortress in 2002 after spending 11 years at Goldman Sachs, where he was elected partner in 1998. Mr.Novogratz founded and serves as the Chairman of the Board for Beat the Streets, a non-profit organization which builds wrestling programs in New York City public schools and is also the Honorary Chairman of USA Wrestling Foundation. Mr. Novogratz is Chairman of The Friends of the Hudson River Park. He also serves on the board of the Acumen Fund, NYU Langone Medical Center, Princeton Varsity Club and The Jazz Foundation of America. Mr. Novogratz received an AB from Princeton University in Economics, and served as a helicopter pilot in the US Army.
Show more...Investment focus
- Blockchain, Cryptocurrency, FinTech
- Funding Round, Seed, Series B
- United States, India, Germany
Portfolio highlights
- Portal — Portal is a financial services company that trades crypto anywhere without putting coins at risk, all from within a controllable wallet. Founded in 2018, Portal is headquartered in San Francisco, California.
- Verandah — Verandah is story based conscious luxury resort brand retailing amongst the top 100 in the global luxury resort wear space with design roots strongly based in India. Verandah also has a line of 100% Italian made sustainable swimwear to compliment the season-less ready to wear line.
- Cambrian Biopharma — Cambrian is developing a raft of new companies and therapies to extend healthy lifespan, bringing proven scientific and organizational expertise to exceptional research teams worldwide.
Carsten Maschmeyer is a successful entrepreneur, consultant and financial investor. He was born on May 8, 1959 in Bremen and grew up in Hildesheim. After his graduation in 1978 Maschmeyer completed military service before he began to study medicine in Hannover. To finance his studies, he worked part-time in sales of investment advice to it in 1982completely dedicated financial advice. More about Carsten Masch Meyers consultant. In 1988 Carsten Maschmeyer to AWD financial group, which was successfully launched on the stock market in 2000 and rise to the MDAX and expanded in 11 countries. Was sold in 2007 Carsten Maschmeyer all his shares in the company at the insurance group Swiss Life, who renamed the AWD in AWD Holding. Maschmeyer has today different occupational focuses, inter alia, as entrepreneur, investor and consultant. His experience Carsten Maschmeyer a sought-after speaker on the subject of success. Motivated by the desire expressed by many listeners to learn more about his secret of success, Carsten Maschmeyer published in the spring of 2012 his book "Self Made - performance live richly". In it he describes the basis of his own exciting path and the celebrities strategies for professional, financial and personal success.
Show more...Investment focus
- Software, Information Technology, Machine Learning
- Seed, Angel, Series A
- Germany, Austria, Switzerland
Portfolio highlights
- frats — frats' goal is to become a solution-oriented company in the party, event, and festival market for sustainable products.
- Futurised — Futurized makes processes simple and intelligent by providing businesses with software robots that automate all unpleasant and complex operations using AI.
- Bildungs urlauber — The goal of Bildungsurlauber.de is to make complicated topics simple. First and foremost, we assist you in locating the appropriate seminar for you by using simple filter options - regardless of whatever federal state you work in.
Thor Bjorgolfsson - Entrepreneur, Businessman and Adventure Capitalist Thor Bjorgolfsson, Iceland’s first and only current billionaire, is an investor and business innovator who is not afraid of risk. He has been an entrepreneur since childhood, making his first deal at the age of 10, when he purchased a stack of vintage Marvel comics withborrowed money.In 2004, he founded Novator Partners, an alternative investment firm. He has strategically developed the company to allow it to maintain maximum flexibility as well as to facilitate investments in both strategic (buy and hold) and financial (buy and exit) opportunities.With Novator, Thor leverages private equity as well as macro investments and manages assets across a variety of sectors and geographic locations. He is an active investor in emerging economies including Central and Eastern Europe as well as Latin America.Novator Partners has been a major player in telecom businesses. Thor is a stakeholder in a Polish telecom company called Play, which went public in 2017. In addition, he holds shares in WOM, a Chilean telecommunications firm.Bjorgolfsson’s first fortune was made in post-soviet Russia. At a time when others perceived Russia to be tumultuous, he saw an underserved market that presented an exciting opportunity to invest in great ideas and businesses. He co-founded and developed Bravo Brewery, which produced beer and alcopops. Bravo became one of Russia’s premier brewing companies, particularly through its popular Botchkarov beer brand. Thor sold the business in 2002 to Heineken for $100 million.With the sale of Bravo, he was able to diversify his holdings by reinvesting in new ventures, focusing on telecommunications, pharmaceuticals, and banks. In a few years, he was able to turn that $100 million into a net worth of over $2.1 billion.A year after being featured on the 2007 cover of Forbes Magazine, Iceland went nearly bankrupt overnight and Thor found himself at the epicenter of the financial crisis. As a major shareholder in Landsbanki with personal guarantees of 350m euro, he refused to declare bankruptcy and eventually succeeded in paying off all of it. He then went on to invest in new businesses, re-establishing himself and being featured on the Forbes list of billionaires once again.During this time of rejuvenation, he wrote Billions to Bust and Back: How I Made, Lost and Rebuilt a Fortune, And What I Learned on the Way (2014). In the book, he shares his perspective of what it was like to be at the center of the storm and how he made it back to financial success. He proposes that the greatest strength an entrepreneur can possess is a positive attitude.The 52-year-old Thor was educated in the United States where he earned a Bachelor of Science degree from New York University. In 2005, he was honored as a Young Global Leader by the World Economic Forum. In spite of his intense schedule, Thor enjoys sharing his experience and business insight, making him a sought-after speaker. A multilingual Icelandic citizen, Thor spends most of his time in London, living with his wife and three children. Thor's personal passion is his collection of six motorcycles, which he rides whenever time permits.
Show more...Investment focus
- Big Data, TV, TV Production
- Seed, Series A, Series C
- United Kingdom, Germany
Portfolio highlights
- Olvin — Using foot traffic analytics to help your business make the right decisions. Get started to access world class data and actionable insights.
- DNEG — We are DNEG, one of the world's leading visual effects and animation studios for feature film and television, honoured with the Academy Award six times
- ATAI Life Sciences — ATAI is a global biotech company builder that leverages a decentralized, technology- and data-driven platform model to serve millions of people suffering from mental health disorders. The company is committed to acquiring and efficiently developing innovative treatments that address significant unmet medical needs and lead to paradigm shifts in themental health space.ATAI Life Sciences was founded in 2018 and is based in Munich, Bayern, Germany.
Jude Gomila is currently CEO and Founder of the startup Golden.
Show more...Investment focus
- Software, Biotechnology, Information Technology
- Seed, Pre-Seed, Angel
- United States, United Kingdom, Canada
Portfolio highlights
- Parcha AI — Parcha is an AI-powered enterprise software that enables businesses to automate their scale compliance and operations.
- Monitaur — Reduce operational overhead, improve security, optimize performance, and deliver amazing customer experiences with our end-to-end, hybrid observability & APM platform built for decentralized apps and infrastructure.
- Gradia Health — Gradia is an integrated, concierge care platform designed for clinics to support patients with chronic conditions.
Mark is currently a Founding Partner and LP and Investment Committee member at Kindred Capital, a European Seed-Stage Venture fund, based in London. He was a General Partner at Balderton Capital/ Benchmark Europe from 2002 through 2015, and an EIR at Benchmark Capital in 1999/2000.He spent the prior 15 years @ Goldman Sachs, where hewas a General Partner and Management Committee member. He studied Economics at both University of Oxford and Queen's University in Canada.
Show more...Investment focus
- Software, E-Commerce, Health Care
- Funding Round, Series A, Seed
- United Kingdom, United States, The Netherlands
Portfolio highlights
- ONI — ONI is a pioneer of super-resolution microscopy, making this advanced technology accessible to new generations of researchers. The Nanoimager, the world's first benchtop sized super-resolution microscope, delivers a step change in usability and precision. This, together with our next-generation consumable products will empower academicresearchers, clinicians and scientists to on a path to discovery.The microscope offers easy access to a range of super-resolution techniques including dSTORM and PALM, as well as smFRET, single-particle tracking and confocal.The company's achievements have been recognised by FastTrack100 who named ONI on their 2018 list of 10 Disruptors to Watch and ONI won Best Business Start-up at the 2018 IOP Awards. More and more life science researchers and pharma companies are taking an interest in ONI and it now has customers using its products in leading laboratories across the globe, including the Universities of Oxford, Cambridge and Harvard.ONI has a restless enthusiasm to make the world a better place. Our ambition is to bring super-resolution fluorescence imaging to a new community of researchers and we are removing barriers to make science more effective, accessible and affordable. Our vision is to accelerate scientific discovery and fight disease by enabling everyone to visualize, understand and share the microscopic details of life.
- Ufonia — Ufonia is replacing routine patient healthcare interactions with next-generation automated phone calls.
- Arctoris — Arctoris is a platform company headquartered in Oxford, with its US operations based in Boston and its APAC operations based in Singapore. Arctoris developed and operates a unique drug discovery platform powered by advanced robotics and data science combined with an experienced team of biotech & pharma veterans. Arctoris actively pursuesseveral drug discovery programs in oncology and neuro, while also providing access to its platform to select biotech and pharma partners. Arctoris' approach of data-driven drug discovery leads to higher chance of success, and an accelerated progression of programs towards the clinic.
Pierre Drion - CEO @ Petercam
Show more...Investment focus
- Biotechnology, Life Science, Software
- Series A, Series B, Funding Round
- Belgium
Portfolio highlights
- A-Mansia Biotech — A-Mansia Biotech is a developer of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacterium. The company's nutritional supplement based on a gut bacterium called Akkermansia, the population of microorganisms housed in the gastrointestinal tract. A. muciniphila is located in the mucus layer covering theintestinal epithelium, which allows the bacterium to establish a close cross-talk with the host.
- Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
- Santero Therapeutics — Santero Therapeutics seeks to provide novel medications with fresh modes of action that combat diseases with high resistance. Santero develops antimicrobials with novel modes of action to combat the rise of antibiotic-resistant microorganisms.
Annie Vereecken
Show more...Investment focus
- Biotechnology, Medical, Hospital
- Seed, Series A, Funding Round
- Belgium
Portfolio highlights
- Ziphius — Ziphius Vaccines is a biopharmaceutical company dedicated to developing next-generation vaccines for the prevention of infectious diseases.
- Sensolus — Introducing our smart, industrial-grade tracking solution. With battery life of up to ten years, and no additional infrastructure needed.
- Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
Ian got a master's in machine learning at Cambridge and loves dystopian robot takeover narratives. Seven years ago, Ian realized being a choirboy came with no street cred, so he started DJing hip-hop, funk, drum & bass, and grime. Ian quit his job at Bain & Company, Singapore to start Songkick.
Show more...Investment focus
- Software, E-Commerce, Health Care
- Seed, Pre-Seed, Series A
- United Kingdom, United States, Germany
Portfolio highlights
- Claimer — Claimer is a self-service application that gets credit claims done easily of money spent on research and development. Its platform empowers company owners and advisors to prepare their claims, without any specialist knowledge, no matter how big or small the claim. It also prepares and submits the amended tax return for free.Claimer was founded in2019 by Adam McCann and is headquartered in Croydon, United Kingdom.
- The Garden — The Garden is an online media company.
- Condense — Live-streamed volumetric video into game engines
Andrew Keys is the Co-Founder and Managing Partner of Andrew Keys. He previously worked for ConsenSys as a Head of Global Business Development. Andrew Keys attended Loyola University Maryland.
Show more...Investment focus
- Software, Finance, Blockchain
- Seed, Pre-Seed, Series A
- United States, India, Norway
Portfolio highlights
- Evertas — Evertas brings this unchanging approach to the new space of crypto assets. Our goal is to help crypto realize its full potential, for everyone.
- Aligned — Aligned is building a suite of products and services aimed to empower the growing decentralized financial movement spanning high performance computing, mining, staking and liquidity provisioning while supporting decentralization with immutable, full-stack infrastructure for DeFi.
- Molecule — Molecule is a collaborative platform, where stakeholders in drug development work together to accelerate the process of bringing novel therapeutics to patients. We connect leading researchers to investment opportunities by turning intellectual property and its development into a liquid and easily investable asset.
Fidji Simo is the CEO and Chair of the Board of Directors of Instacart. She previously worked at Facebook as a Head of the Facebook App. Fidji Simo attended HEC Paris.
Show more...Investment focus
- Software, Health Care, Information Technology
- Seed, Series A, Series B
- United States, United Kingdom, France
Portfolio highlights
- GOURMEY — We create sustainable cultivated meat delights for an uncompromising and conscious generation.
- Polywork — Launch an AI-powered personal website to showcase your work, grow your personal brand, or start your side hustle.
- Archy — SaaS Practice Management Software for Dental Practices
Jon Oringer is the founder and chairman of Shutterstock.
Show more...Investment focus
- Software, Information Technology, E-Commerce
- Seed, Pre-Seed, Funding Round
- United States, France, United Kingdom
Portfolio highlights
- Skedway — Every work experience should be great! Skedway is the complete platform to optimize the hybrid work experience.
- Zamp — We give you freedom from sales tax! Eliminate the need to learn, manage or touch any part of the sales tax compliance process.
- NewHomesMate (formerly Propertymate) — Find, compare and buy a new construction home - all in one place.
Inaki Berenguer is the President and Co-founder at iPronics Programmable Photonics.
Show more...Investment focus
- E-Commerce, FinTech, Enterprise Software
- Seed, Angel, Pre-Seed
- Spain, United States, United Kingdom
Portfolio highlights
- Paack — Find the ideal delivery solution to integrate to your e-commerce. We adapt to your retail, offering your customer an amazing delivery experience.
- Libera Bio — Libera Bio is a biopharmaceutical company devoted to the development of a new class of therapeutics to address unmet medical needs in cancer
- Mable (Neurolytic Healthcare) — Neurolytic Healthcare provides personalized medicine for neurological conditions. Neurolytic Healthcare collects and extracts insights from a combination of genetic and biomarker data to enhance diagnosis and help clinicians decide on optimal treatment strategies for neurological conditions.The company delivers digitally and genomically-drivenmedical devices to improve the current treatment of migraine and other neurological disorders, including a diagnostic support tool, pharmacogenetic test, and a mobile app for migraine event prediction.
Michelle Tempest
Show more...Investment focus
- Health Care, Cannabis, Life Science
- Seed, Series A
- United Kingdom
Portfolio highlights
- Daye — Sustainable, clinically validated organic CBD tampons and ProViotics for vaginal health, delivered to your door. Good for your body and the environment.
- Medwise.ai — Medwise.ai is the Google for doctors.
Sami Mikati is a Director of Synthace Ltd. Investor and commercial executive with deep experience and network across energy and engineering industries in Europe, the Middle East and Africa.
Show more...Investment focus
- Biotechnology, Software, Life Science
- Seed
- India, United Kingdom
Portfolio highlights
- CyGenica — CyGenica uses a non-viral, non-toxic platform to develop in vitro and in vivo delivery solutions for drugs, gene editing components, and antibiotics.
- Synthace — The Synthace Experiment Platform lets you design powerful experiments, run them in your lab, & gather automatically structured datasets. No code necessary.
I am a food scientist, entrepreneur and investor. Through SFV (sustainablefoodventures.com), I back founders building the future of cell-based, plant-based and recombinant food.
Show more...Investment focus
- Seafood, Wellness, Life Science
- Pre-Seed
- Spain, Iceland
Portfolio highlights
- Loki Foods — We're producing sustainable, plant-based foods from the Arctic. Iceland’s first plant-based cod and seafood!
- Sobo Foods — Sobo Foods is a plant based comfort food provider.
- Libre Foods — Libre Foods is a biotech startup on a mission to liberate the food system and create a more free future for people, the planet, and animals. The company was founded in 2020 and is based in Barcelona, Catalonia, Spain.
Arturo Elizondo is CEO of Clara Foods, a sustainable ingredients company making the world’s most comprehensive egg white substitute. Clara leverages advances in fermentation technology to bring an egg white to the table that is completely animal-free, far more sustainable, and free of salmonella without compromising the qualities we know and love.Prior to joining Clara Foods, Arturo worked at the investment bank Credit Suisse, U.S. Department of Agriculture, and under Supreme Court Justice Sonia Sotomayor.
Show more...Investment focus
- Wellness, Life Science, Biotechnology
- Seed, Pre-Seed
- Spain, Switzerland
Portfolio highlights
- Libre Foods — Libre Foods is a biotech startup on a mission to liberate the food system and create a more free future for people, the planet, and animals. The company was founded in 2020 and is based in Barcelona, Catalonia, Spain.
- Cultivated Biosciences — Cultivated - Creamy, dairy-free indulgence
Bertrand Jacquelot is the Founding President of Projim. He attended the University of Marne-la-Vallee.
Show more...Investment focus
- E-Commerce, Information Technology, Food and Beverage
- Pre-Seed, Seed, Angel
- France, United States
Portfolio highlights
- Bolk — Bolk provides autonomous bowl-making robotic canteen which producing warm meals, cold dishes and desserts from precooked ingredients.
- Arkania — B2B API solution for brands to create and sell online NFTs directly on their platforms
- Starton — Integrate blockchain technology this week. Focus on your vision, we handle blockchain complexity
David Brandes - Managing Director & Co-Founder @ Peace of Meat
Show more...Investment focus
- Wellness, Life Science, Biotechnology
- Seed
- Spain
Portfolio highlights
- Libre Foods — Libre Foods is a biotech startup on a mission to liberate the food system and create a more free future for people, the planet, and animals. The company was founded in 2020 and is based in Barcelona, Catalonia, Spain.
Dr. Milad Alucozai is an Afghan-American neuroscientist, entrepreneur, biotech executive, and global investor with nearly two decades of experience in deep tech, primarily in life sciences. He pushes the boundaries of bioengineering and computational advancements, integrating machine learning and artificial intelligence into biology and medicine.With a strong commitment to commercializing transformative technologies and fostering startup ecosystems worldwide, he is a thought leader and formal mentor for entrepreneurs through organizations like Creative Destruction Lab and the Wyss Institute at Harvard Medical School.Currently, Milad is the head of Bio and Deep Tech at BoxOne Ventures, where he spearheads the firm’s investments in early-stage companies with breakthrough scientific ideas. With nearly 80 early-stage investments, they are recognized as one of North America’s most active venture firms. He is also a Venture Partner at Entrepreneur First, a global fund that has built over 500 companies from scratch with an enterprise value of $10bn. He supports founders with strategy, scaling, business development, securing growth capital, and leadership training, often being their first investor and guiding them from startup inception to IPOs or acquisitions.He started his career in translational neuroscience and multiphysics laboratories before transitioning into founding roles at biotech startups. He is part of the founding team at Mekonos, a San Francisco-based company creating a proprietary cell-engineering platform to support the future of cell and gene therapies. He was also part of the founding team at Corstem, which specialized in machine learning and artificial intelligence software and was later acquired by Circle Cardiovascular, a platform in over 1000 hospitals and more than 40 countries. At Accenture, Milad directed teams of data scientists, designers, and engineers in developing artificial intelligence platforms for global pharmaceutical companies and hospital networks.Milad serves as a Fellow in Healthcare Engineering at the Regenstrief Center. In 2020, he served as an External Advisor to AstraZeneca. He was recognized as a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program. As a George J. Mitchell Scholar, he completed his master’s in Immunology and earned his doctorate from the Richard M. Fairbanks School of Public Health.
Show more...Investment focus
- Biotechnology, Health Care, Medical
- Seed, Series A, Pre-Seed
- United States, Canada, United Kingdom
Portfolio highlights
- Arpeggio Bio — Arpeggio Biosciences leverages state of the art sequencing approaches coupled with powerful machine learning to uncover novel insights into a compound's biological mechanism of action.The company is diverse set of molecular biologists, computer scientists, and biotechnology enthusiasts passionate about understanding where, why, and howtherapeutics work.
- Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
- Eigen Therapeutics — Eigen Therapeutics is a biotechnology company developing combination therapeutics for cancer. The company is in the research and development of synergistic therapies that improve efficacy while reducing the toxicity of small molecule therapies and immunotherapies, enabling physicians to get access to novel drugs in areas of unmet medical needs.
David Lucas
Show more...Investment focus
- Software, Life Science, Biotechnology
- Seed
- United Kingdom
Portfolio highlights
- Synthace — The Synthace Experiment Platform lets you design powerful experiments, run them in your lab, & gather automatically structured datasets. No code necessary.
Arnaldo Marziali
Show more...Investment focus
- Big Data, Software, Life Science
- Pre-Seed
- Spain
Portfolio highlights
- Seqera Labs — Seqera Labs is a Barcelona-based business creating solutions for high-performance computing workloads across cloud and clusters. It was founded by the creators of the popular open-source workflow software Nextflow (http://www.nextflow.io).
Laura Iris Ferro
Show more...Investment focus
- Health Care, Biotechnology, Medical Device
- Pre-Seed, Funding Round
- Italy
Portfolio highlights
- Newronika — Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
- Bio4Dreams — Il primo incubatore italiano certificato di startup innovative in fase very early stage, a capitale totalmente privato, dedicato alle Scienze della Vita.
Sophia Bendz - Partner @ Cherry Ventures
Show more...Investment focus
- Health Care, Software, Apps
- Seed, Pre-Seed, Funding Round
- Sweden, United Kingdom, United States
Portfolio highlights
- mayk — Mayk sounds. Mayk music. Mayk noise. Mayk it... In an app.
- Medoma — Medoma is a Swedish virtual ward company that offer patients acute hospital care in their home instead of in the hospital.
- Wikifarmer — A free online knowledge library where professional or amateur farmers can find best practices on growing their fields more effectively and an online marketplace where farmers can sell their products to buyers directly. Our vision is to create a fair, transparent and profitable environment for all the farming world. Farmers are dedicating theirlives in cultivating their fields, but get the lowest value of all the sales cycle, so we believe they need to receive a more fair share. Buyers have the right to have more options and buy at better prices, so we want to be the ones to solve this inequality in both sides.
Sharaf Yamani - Managing Director @ Windlesham Advisors
Show more...Investment focus
- Biotechnology, Software, Life Science
- Seed
- India, United Kingdom
Portfolio highlights
- CyGenica — CyGenica uses a non-viral, non-toxic platform to develop in vitro and in vivo delivery solutions for drugs, gene editing components, and antibiotics.
- Synthace — The Synthace Experiment Platform lets you design powerful experiments, run them in your lab, & gather automatically structured datasets. No code necessary.
Josefin Landgård is the Founder and CEO of Mantle. Previously she served as the Co-Founder and COO at KRY back in March 2014 to September 2018.
Show more...Investment focus
- Health Care, Medical, Women's
- Seed, Angel, Pre-Seed
- Sweden, France
Portfolio highlights
- Estrid — Estrid is an online portal that offers women's personal care products.
- Lassie — Lassie is the first proactive and preventive pet insurance company that wants to help pet owners take better care of their pets
- Elsa — Elsa is a platform for patient driven research for better drugs, health and prevention. Elsa lets patients become their own personal researchers by providing them with a better understanding around how lifestyle factors may affect their disease activity measurements for chronic disease. To support them from a scientific perspective, Elsa gives themaccess to data on their specific disease (initially we work with rheumatoid arthritis) through the Riskminder foundation and scientific studies at Karolinska Institutet.
Ritu Bansal-Mutalik is a Senior Director, Process Research and Development at ZymoChem.
Show more...Investment focus
- Wellness, Life Science, Biotechnology
- Seed
- Spain
Portfolio highlights
- Libre Foods — Libre Foods is a biotech startup on a mission to liberate the food system and create a more free future for people, the planet, and animals. The company was founded in 2020 and is based in Barcelona, Catalonia, Spain.
Barbara Korte-Sturm
Show more...Investment focus
- Life Science, Biotechnology
- Seed
- Germany
Portfolio highlights
- DNTOX — We are building up a bioanalytical testing laboratory for animal-free screening of chemicals, regarding their potential to disturb brain development and cause developmental neurotoxicity (DNT). Our in vitro testing battery is based on human cell models and enables chemical screening in a high-content and medium-throughput fashion. Furthermore, itis supported by an in-house developed software, using artifical intelligence. We support our customers during the identification of safe lead structures during substance development, as well as the safety assessment during approval and re-approval processes of chemicals. With our innovation, we want to realize our company vision: Safe chemicals without animal experiments!
Ryan is a co-founder and CEO at Wild Earth and a co-founder and Partner at Sustainable Food Ventures, bringing years of experience in leading, building and advising high-growth food and biotechnology companies. Ryan is a biotech entrepreneur, investor, and one of the founders of the biohacker movement. He’s a co-founder and former Program Directorat IndieBio and has invested in over 130 early stage biotech startups and served as the head of life sciences at the XPRIZE Foundation. As an ethical vegan, Ryan is passionate about the future of biology as a technology, applied across all industries to solve some of humanity’s most intractable problems. Ryan fosters dogs for Rocket Dog Rescue and is passionate about mindfulness, meditation, and mentoring. His work at the interface of science, food, and business has been covered by many major publications.
Show more...Investment focus
- Biotechnology, Food Processing, Food and Beverage
- Pre-Seed, Seed, Angel
- United States, Chile, India
Portfolio highlights
- WTH Foods — WTH Foods is a plant-based alternative protein company based in Manila, Philippines. Using local and sustainable ingredients, we create plant-based versions of processed meat products that Southeast Asian love
- Sobo Foods — Sobo Foods is a plant based comfort food provider.
- Libre Foods — Libre Foods is a biotech startup on a mission to liberate the food system and create a more free future for people, the planet, and animals. The company was founded in 2020 and is based in Barcelona, Catalonia, Spain.
Balaji S. Srinivasan is the Co-Founder and Board Member of Coin Center. He was the CTO of Coinbase and cofounder of Counsyl, Earn, Teleport, and Coin Center. He was previously CEO at Earn.com, which was recently sold to Coinbase. Prior to taking the CEO role at Earn.com, Dr. Srinivasan was a General Partner at Andreessen Horowitz. Prior to joininga16z, he was the cofounder and CTO of Founders Fund-backed Counsyl, where he won the Wall Street Journal Innovation Award for Medicine and was named to the MIT TR35. Dr. Srinivasan holds a BS, MS, and PhD in Electrical Engineering and an MS in Chemical Engineering from Stanford University. He also teaches the occasional class at Stanford, including an online MOOC in 2013 which reached 250,000+ students worldwide.
Show more...Investment focus
- Blockchain, Cryptocurrency, Software
- Seed, Series A, Pre-Seed
- United States, India, Singapore
Portfolio highlights
- Induced AI — Induced AI works to automate browser tasks. It runs a cloud to complete manual tasks on a browser with human-like reasoning capabilities.
- Parallax — Receive money as if you were abroad. Save big with best rates and lowest fees. Withdraw instantly.
- Proof of Play — We are a team of veteran game developers and entrepreneurs creating onchain games and open source technology. Our vision is simple: to create generation-defining games that fundamentally grant power and ownership to the players who play them.
Arman Anatürk is Co-Founder @ FoodHack.
Show more...Investment focus
- Biotechnology, Food and Beverage, Wellness
- Seed, Pre-Seed
- Spain, Israel, Germany
Portfolio highlights
- Bosque Foods — Kinoko Labs develops the next generation of meat substitutes, starting with whole-cut meat items made from fungal mycelium produced organically. Headquartered in New York.
- Libre Foods — Libre Foods is a biotech startup on a mission to liberate the food system and create a more free future for people, the planet, and animals. The company was founded in 2020 and is based in Barcelona, Catalonia, Spain.
- Kynda — Keen 4 Greens offers a wide range of vegan products. Founded in 2019, Keen 4 Greens is based in Hamburg, Germany.
Fiona is Managing Partner at Crista Galli Ventures, an early stage healthtech VC fund based in London and Copenhagen.
Show more...Investment focus
- Health Care, Biotechnology, Wellness
- Pre-Seed, Seed, Series A
- United Kingdom, Germany, Armenia
Portfolio highlights
- Melon — Save & organise content from any source. Follow experts and friends. Share your knowledge with others.
- Bloom Money — Bloom Money is a savings club app designed to help growing communities in migrant communities and use technology to promote community, safety, and convenience.
- Storia — Capture your thoughts and unleash your inner voice
Early stage investor in techbio
Show more...Investment focus
- Software, Blockchain, Health Care
- Seed
- Germany
Portfolio highlights
- Molecule — Molecule is a collaborative platform, where stakeholders in drug development work together to accelerate the process of bringing novel therapeutics to patients. We connect leading researchers to investment opportunities by turning intellectual property and its development into a liquid and easily investable asset.
Jon Oringer is the founder and chairman of Shutterstock.
Show more...Investment focus
- Software, Information Technology, E-Commerce
- Seed, Pre-Seed, Funding Round
- United States, United Kingdom, France
Portfolio highlights
- Skedway — Every work experience should be great! Skedway is the complete platform to optimize the hybrid work experience.
- Zamp — We give you freedom from sales tax! Eliminate the need to learn, manage or touch any part of the sales tax compliance process.
- NewHomesMate (formerly Propertymate) — Find, compare and buy a new construction home - all in one place.
Kristian Ranta is a Co-Founder & Chief Executive Officer at Meru Health.
Show more...Investment focus
- Health Care, Apps, Internet
- Seed
- Finland, United States
Portfolio highlights
- Solu — Discover the next generation toolkit for analyzing, storing and sharing bacterial genomes.
- Veri — Reveal the foods that help you feel and perform at your best. Track your metabolic health to manage weight, reduce stress and improve sleep.
- Vital — Vital is an API for wearables, medical devices and lab tests. We make it easy to connect to hundreds of wearables such as Oura, Garmin, Fitbit, Omron, and deliver at home custom branded lab tests through an API.
Sebastian Lombardo - CEO @ Valtech
Show more...Investment focus
- Apps, Internet, Lifestyle
- Seed
- France, United States
Portfolio highlights
- Jop — A one-stop-shop for urban residents, Jop offers a variety of on-demand services in one convenient, easy-to-use platform. Customers can tap a screen and connect with a professional in their city, whether they are an expert at cleaning apartments, trimming mustaches, walking dogs, doing makeup, DJing, or mixing drinks. Instead of paying a company’soverhead, customers pay a Jopper. Once booked, Joppers arrive right at the customer’s doorstep, ready to work.Founded by Canel Frichet and Sebastian Lombardo, Jop was born as a platform to give people the opportunity to work directly for each other, as opposed to hiring through a company. Joppers set their own pricing and hours. Something else that sets JOP apart from other platforms in the on-demand space is that Joppers earn company equity, which is granted based on level of activity and performance on the platform.
- Smart Immune — Smart Immune is a clinical-stage biotechnology company focused on developing the next generation of hematopoietic stem cell-based biotherapies to change the prognosis and life quality of patients with devastating diseases. The company's first cell therapy program is based on T cell progenitors or ProTcellsTM (CD7+/CD34-; CD5- cells)curative power to enable a short, polyclonal, and safe post-transplantation immune recovery. This program be completed by integrative developments from targeted conditioning to gene therapy and genome editing enabling clinicians to access new-generation treatments for a wide variety of inherited blood disorders and blood cancers.
Simon is the joint founder and CEO of Redgate Software. Over the past 15 years, Simon has been part of Redgate’s growth from a 2 person firm operating out of a spare room to today’s 300 person outfit with hundreds of thousands of users. Although Simon’s responsibilities are primarily strategic, his background is technical with qualificationsincluding a PhD in physics from Cambridge University and former employment with Shell and ThornEMI.
Show more...Investment focus
- Software, Health Care, Life Science
- Pre-Seed, Funding Round
- Croatia, United Kingdom
Portfolio highlights
- BoobyBiome — BoobyBiome uses specialist expertise and research to develop a probiotic supplement for infants with compromised microbiomes. We aim to promote healthy infant development by recreating the beneficial bacteria associated with breast milk.
- SysKit — Syskit is a software development company specialized in enterprise tools for Microsoft 365, SharePoint, Windows Server, Remote Desktop Services, Citrix.
John Anthony Knight
Show more...Investment focus
- Software, Life Science, Biotechnology
- Seed
- United Kingdom
Portfolio highlights
- Synthace — The Synthace Experiment Platform lets you design powerful experiments, run them in your lab, & gather automatically structured datasets. No code necessary.
Close your round
Find who invests in your industry, stage, and region in our 200k+ database with AI-powered matching.
Find investors — It's Free!Join 21,000+ founders from: